| Nicole Butler, | |
|
8 Blenheim Dr, Doylestown, PA 18902-9403 | |
| (215) 837-3379 | |
| Not Available |
| Full Name | Nicole Butler |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 8 Blenheim Dr, Doylestown, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861847832 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Nicole Butler, 8 Blenheim Dr, Doylestown, PA 18902-9403 Ph: (215) 837-3379 | Nicole Butler, 8 Blenheim Dr, Doylestown, PA 18902-9403 Ph: (215) 837-3379 |
News Archive
Varian Medical Systems today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a Calypso® soft tissue Beacon® transponder that can help enhance the precision of radiotherapy and radiosurgery treatments for cancer.
New classes of drugs that can silence specific genes, such as small interfering RNAs (siRNAs), offer great therapeutic potential. But the specific delivery of siRNAs to target cells to exert their effects remains a significant challenge. A novel nanoparticle-based approach that enables more efficient delivery of siRNA drugs is presented in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers.
Relocating to a newly designed neonatal intensive care nursery significantly reduces severe late-onset sepsis rates in very-preterm and/or very-low-birthweight infants, although it remains relatively common, conclude Australian scientists.
Novartis Pharmaceuticals Corporation announced today that results from a Phase II study show Afinitor® (everolimus) tablets is the first medication in a clinical trial to decrease the size of subependymal giant cell astrocytomas (SEGAs), benign brain tumors associated with tuberous sclerosis (TS). In this study of 28 patients presented today at the 46th American Society of Clinical Oncology (ASCO) annual meeting in Chicago, 75% of patients experienced a reduction of 30% or greater in the size of their brain tumors from baseline to six months (p<0.001).
› Verified 1 days ago
Jennifer Lauren Guido, M.A., LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 800 W State St, Suite 303, Doylestown, PA 18901 Phone: 267-629-5274 | |
Ms. Charlene Cecelia Mehra, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 3719 William Daves Rd., Doylestown, PA 18902 Phone: 215-348-5555 Fax: 215-489-5052 | |
Meghan Barbara Jerry, MFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 350 S Main St, Suite 306, Doylestown, PA 18901 Phone: 267-603-1624 | |
Stephanie Lewis, MAMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 500 N West St, Doylestown, PA 18901 Phone: 215-399-8034 | |
Alyssa Mawson, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 4451 W Swamp Rd, Doylestown, PA 18902 Phone: 267-574-1620 | |
Prof. Cheryl H Litzke, MFT, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: Park Terrace Ofcs., 275 S. Main St., Suite 2d, Doylestown, PA 18901 Phone: 215-345-5665 | |
Aparna Sagaram, MFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 350 S Main St Ste 306, Doylestown, PA 18901 Phone: 267-225-4428 |